Builders FirstSource
BLDR
The Kroger
KR
Eli Lilly and Co
LLY
Stanley Black & Decker
SWK
Merck & Co
MRK
(Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.25M | 367.23K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 613.72K |
Operating revenue | --2.25M | --367.23K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --613.72K |
Cost of revenue | 1.6M | 224.1K | 0 | -16.72K | -16.72K | 0 | 0 | 0 | 0 | 466.73K |
Gross profit | 653.89K | 143.13K | 0 | 16.72K | 16.72K | 0 | 0 | 0 | 0 | 146.99K |
Operating expense | 4,200.96%395.47K | -1,818.26%-153.68K | -3,398.93%-295.06K | -132.89%-106.91K | -133.99K | 9.2K | 8.94K | 8.94K | -50.33%325.03K | 654.41K |
Selling and administrative expenses | 4,200.96%395.47K | -1,818.26%-153.68K | -3,398.93%-295.06K | -132.89%-106.91K | ---133.99K | --9.2K | --8.94K | --8.94K | -50.33%325.03K | --654.41K |
-Selling and marketing expense | --106K | --10K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --3.62K |
-General and administrative expense | 3,048.16%289.47K | -1,930.06%-163.68K | -3,398.93%-295.06K | -132.89%-106.91K | ---133.99K | --9.2K | --8.94K | --8.94K | -50.06%325.03K | --650.8K |
Research and development costs | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Depreciation amortization depletion | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Depreciation and amortization | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Operating profit | 2,910.42%258.42K | 3,418.55%296.81K | 3,398.93%295.06K | 138.04%123.63K | 150.72K | -9.2K | -8.94K | -8.94K | 35.94%-325.03K | -507.42K |
Net non-operating interest income expense | -10.97%-103.12K | -10.94%-102.29K | -25.14%-109.4K | -3.76%-384.72K | -112.17K | -92.92K | -92.2K | -87.42K | -0.52%-370.77K | -368.84K |
Non-operating interest income | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Non-operating interest expense | 10.97%103.12K | 10.94%102.29K | 25.14%109.4K | 3.76%384.72K | --112.17K | --92.92K | --92.2K | --87.42K | 0.52%370.77K | --368.84K |
Other net income (expense) | -40.81%3.11M | 3.1M | 12.3K | 5.25M | ||||||
Special income (charges) | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 |
-Gain on sale of property,plant,equipment | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- | --0 | --0 |
Other non- operating income (expenses) | ---- | ---- | ---- | -40.81%3.11M | --3.1M | ---- | ---- | --12.3K | --5.25M | ---- |
Income before tax | 252.08%155.3K | 292.32%194.52K | 320.85%185.66K | -37.50%2.85M | 3.13M | -102.12K | -101.15K | -84.06K | 619.73%4.55M | -876.26K |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | 252.08%155.3K | 292.32%194.52K | 320.85%185.66K | -37.50%2.85M | 3.13M | -102.12K | -101.15K | -84.06K | 619.73%4.55M | -876.26K |
Net income continuous Operations | 252.08%155.3K | 292.32%194.52K | 320.85%185.66K | -37.50%2.85M | --3.13M | ---102.12K | ---101.15K | ---84.06K | 619.73%4.55M | ---876.26K |
Minority interest income | ||||||||||
Net income attributable to the parent company | 252.08%155.3K | 292.32%194.52K | 320.85%185.66K | -37.50%2.85M | 3.13M | -102.12K | -101.15K | -84.06K | 619.73%4.55M | -876.26K |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 252.08%155.3K | 292.32%194.52K | 320.85%185.66K | -37.50%2.85M | 3.13M | -102.12K | -101.15K | -84.06K | 619.73%4.55M | -876.26K |
Basic earnings per share | 252.17%0 | 273.91%0 | 315.79%0 | -37.50%0.0006 | 0.0007 | -0 | -0 | -0 | 618.37%0.001 | -0.0002 |
Diluted earnings per share | 252.17%0 | 273.91%0 | 315.79%0 | -37.50%0.0006 | 0.0007 | -0 | -0 | -0 | 618.37%0.001 | -0.0002 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unaudited | -- | -- | -- | -- | Unaudited | -- |